T. Rowe Price Health Care ETF Rating $26.07 +0.02 (+0.08%) As of 01:46 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatingsTrendsBuy This Stock T. Rowe Price Health Care ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.TMED Aggregate RatingModerate Buy 2.72Holdings in TMED have an aggregate rating of Moderate Buy based on 489 analyst ratings issued in the past year covering 25 companies (73.5% of the portfolio).TMED Aggregate Price Target$26.07High Prediction$26.07Average Prediction$26.07Low Prediction$26.07Holdings in TMED have an aggregate price target of $26.07 and a range of $26.07 to $26.07 covering 25 companies (73.5% of the portfolio).TMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy20 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by T. Rowe Price Health Care ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 TMED Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings13.82%LLYEli Lilly and Company$742.51-0.6%4.9978 of 5 stars2.67$939.61 26.5%24Trending News7.89%UNHUnitedHealth Group$351.87+1.2%4.9049 of 5 stars2.52$358.95 2.0%25Trending News6.58%ABBVAbbVie$220.11-1.1%4.8008 of 5 stars2.93$223.45 1.5%27Positive NewsAnalyst ForecastAnalyst Revision5.13%ABTAbbott Laboratories$133.80-1.5%4.9527 of 5 stars2.90$145.22 8.5%21Positive NewsDividend Announcement3.69%GILDGilead Sciences$113.67-0.6%4.935 of 5 stars2.89$117.17 3.1%28Positive News3.66%ISRGIntuitive Surgical$443.99-0.8%4.952 of 5 stars2.60$595.95 34.2%20Positive News3.51%BDXBecton, Dickinson and Company$185.92-0.3%4.9594 of 5 stars2.36$213.30 14.7%11Positive News3.47%DHRDanaher$185.90-2.0%4.9897 of 5 stars2.85$245.91 32.3%20Positive NewsAnalyst Forecast2.51%ELANElanco Animal Health$18.76+1.2%2.5781 of 5 stars2.78$18.33 -2.3%9Positive NewsAnalyst Forecast2.33%CYTKCytokinetics$48.29-0.5%4.222 of 5 stars2.88$75.71 56.8%16Trending NewsAnalyst ForecastAnalyst Revision2.00%REGNRegeneron Pharmaceuticals$576.98+1.6%4.7458 of 5 stars2.82$817.67 41.7%28Positive News1.95%CVSCVS Health$76.36-0.2%4.9119 of 5 stars2.96$78.25 2.5%24Trending NewsDividend AnnouncementAnalyst Upgrade1.68%AAgilent Technologies$124.30-1.3%4.5512 of 5 stars2.50$140.08 12.7%12Positive NewsDividend Announcement1.67%ASNDAscendis Pharma A/S$193.28-0.4%2.9769 of 5 stars3.00$244.36 26.4%151.52%ACLXArcellx$78.75-0.5%2.2775 of 5 stars3.13$114.31 45.2%151.43%EWEdwards Lifesciences$74.71+0.2%4.7361 of 5 stars2.70$86.61 15.9%23Positive NewsAnalyst Upgrade1.42%HUMHumana$262.14+1.5%4.6197 of 5 stars2.29$289.50 10.4%24Analyst Forecast1.29%CORCencora$308.33+2.0%4.735 of 5 stars2.75$311.25 0.9%12Positive NewsInsider Trade1.23%MCKMcKesson$760.73+2.6%4.8159 of 5 stars2.86$826.91 8.7%14Trending NewsAnalyst ForecastAnalyst Revision1.21%TMOThermo Fisher Scientific$467.91-0.4%4.9807 of 5 stars2.76$588.35 25.7%21Positive News1.20%MTDMettler-Toledo International$1,241.91-1.2%4.1489 of 5 stars2.50$1,325.56 6.7%10Positive NewsAnalyst Forecast1.17%BIIBBiogen$137.67-1.2%4.6489 of 5 stars2.32$181.65 31.9%31Trending NewsAnalyst Forecast1.08%DXCMDexCom$67.50-1.0%4.9733 of 5 stars2.91$99.89 48.0%221.03%HOLXHologic$66.40-1.8%4.8771 of 5 stars2.59$79.38 19.6%17Analyst UpgradeInsider Trade1.01%MDTMedtronic$95.64+0.7%4.9381 of 5 stars2.65$102.27 6.9%20Positive News This page (NASDAQ:TMED) was last updated on 9/24/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding T. Rowe Price Health Care ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share T. Rowe Price Health Care ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TMED Stock Alerts